- Home
- ARBE vs FENC Comparison
ARBE vs FENC Comparison
Compare ARBE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- FENC
- Stock Information
- Founded
- ARBE 2015
- FENC 1996
- Country
- ARBE Israel
- FENC United States
- Employees
- ARBE N/A
- FENC N/A
- Industry
- ARBE EDP Services
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARBE Technology
- FENC Health Care
- Exchange
- ARBE Nasdaq
- FENC Nasdaq
- Market Cap
- ARBE 161.8M
- FENC 172.8M
- IPO Year
- ARBE N/A
- FENC 2001
- Fundamental
- Price
- ARBE $1.70
- FENC $5.92
- Analyst Decision
- ARBE Strong Buy
- FENC Strong Buy
- Analyst Count
- ARBE 2
- FENC 2
- Target Price
- ARBE $3.00
- FENC $14.00
- AVG Volume (30 Days)
- ARBE 191.3K
- FENC 165.5K
- Earning Date
- ARBE 11-27-2024
- FENC 11-07-2024
- Dividend Yield
- ARBE N/A
- FENC N/A
- EPS Growth
- ARBE N/A
- FENC N/A
- EPS
- ARBE N/A
- FENC N/A
- Revenue
- ARBE $1,016,000.00
- FENC $49,348,000.00
- Revenue This Year
- ARBE $1.56
- FENC $97.94
- Revenue Next Year
- ARBE $395.31
- FENC $11.50
- P/E Ratio
- ARBE N/A
- FENC N/A
- Revenue Growth
- ARBE N/A
- FENC 278.09
- 52 Week Low
- ARBE $1.40
- FENC $3.96
- 52 Week High
- ARBE $2.57
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- ARBE 39.74
- FENC 54.12
- Support Level
- ARBE $1.58
- FENC $5.51
- Resistance Level
- ARBE $1.75
- FENC $6.17
- Average True Range (ATR)
- ARBE 0.07
- FENC 0.37
- MACD
- ARBE -0.01
- FENC -0.08
- Stochastic Oscillator
- ARBE 20.50
- FENC 32.61
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.